(FFN) Ciencias Farmacéuticas
Departamento académico
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (1)
2007
-
Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors
Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 11, pp. 1324-1337